nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—PLAU—stomach cancer	0.68	1	CbGaD
Amiloride—PLAU—blood vessel—stomach cancer	0.00541	0.0605	CbGeAlD
Amiloride—AOC1—hematopoietic system—stomach cancer	0.00317	0.0355	CbGeAlD
Amiloride—SLC9A1—hematopoietic system—stomach cancer	0.00304	0.034	CbGeAlD
Amiloride—SCNN1D—epithelium—stomach cancer	0.00296	0.033	CbGeAlD
Amiloride—PLAU—hematopoietic system—stomach cancer	0.00288	0.0322	CbGeAlD
Amiloride—SLC9A1—epithelium—stomach cancer	0.00278	0.0311	CbGeAlD
Amiloride—SLC9A1—smooth muscle tissue—stomach cancer	0.00268	0.0299	CbGeAlD
Amiloride—PLAU—epithelium—stomach cancer	0.00263	0.0294	CbGeAlD
Amiloride—PLAU—smooth muscle tissue—stomach cancer	0.00254	0.0284	CbGeAlD
Amiloride—SCNN1B—epithelium—stomach cancer	0.0025	0.0279	CbGeAlD
Amiloride—SLC9A1—pancreas—stomach cancer	0.00248	0.0277	CbGeAlD
Amiloride—PLAU—pancreas—stomach cancer	0.00235	0.0262	CbGeAlD
Amiloride—SCNN1A—epithelium—stomach cancer	0.00231	0.0258	CbGeAlD
Amiloride—AOC1—digestive system—stomach cancer	0.00221	0.0247	CbGeAlD
Amiloride—SLC9A1—lymphoid tissue—stomach cancer	0.00214	0.0239	CbGeAlD
Amiloride—SLC9A1—digestive system—stomach cancer	0.00211	0.0236	CbGeAlD
Amiloride—SCNN1A—pancreas—stomach cancer	0.00206	0.023	CbGeAlD
Amiloride—AOC1—bone marrow—stomach cancer	0.00203	0.0227	CbGeAlD
Amiloride—PLAU—lymphoid tissue—stomach cancer	0.00203	0.0227	CbGeAlD
Amiloride—PLAU—digestive system—stomach cancer	0.002	0.0224	CbGeAlD
Amiloride—SLC9A1—bone marrow—stomach cancer	0.00195	0.0218	CbGeAlD
Amiloride—SCNN1D—endocrine gland—stomach cancer	0.00186	0.0208	CbGeAlD
Amiloride—PLAU—bone marrow—stomach cancer	0.00185	0.0206	CbGeAlD
Amiloride—ASIC1—endocrine gland—stomach cancer	0.00182	0.0204	CbGeAlD
Amiloride—AOC1—endocrine gland—stomach cancer	0.00182	0.0204	CbGeAlD
Amiloride—SCNN1A—digestive system—stomach cancer	0.00176	0.0196	CbGeAlD
Amiloride—SLC9A1—endocrine gland—stomach cancer	0.00175	0.0195	CbGeAlD
Amiloride—SCNN1D—liver—stomach cancer	0.00167	0.0187	CbGeAlD
Amiloride—PLAU—endocrine gland—stomach cancer	0.00166	0.0185	CbGeAlD
Amiloride—AOC1—liver—stomach cancer	0.00164	0.0184	CbGeAlD
Amiloride—SLC9A1—liver—stomach cancer	0.00157	0.0176	CbGeAlD
Amiloride—SCNN1B—endocrine gland—stomach cancer	0.00157	0.0175	CbGeAlD
Amiloride—PLAU—liver—stomach cancer	0.00149	0.0167	CbGeAlD
Amiloride—SCNN1A—endocrine gland—stomach cancer	0.00145	0.0162	CbGeAlD
Amiloride—SCNN1A—liver—stomach cancer	0.00131	0.0146	CbGeAlD
Amiloride—SCNN1D—lymph node—stomach cancer	0.00128	0.0144	CbGeAlD
Amiloride—AOC1—lymph node—stomach cancer	0.00126	0.0141	CbGeAlD
Amiloride—ASIC1—lymph node—stomach cancer	0.00126	0.0141	CbGeAlD
Amiloride—SLC9A1—lymph node—stomach cancer	0.00121	0.0135	CbGeAlD
Amiloride—PLAU—lymph node—stomach cancer	0.00114	0.0128	CbGeAlD
Amiloride—SCNN1B—lymph node—stomach cancer	0.00109	0.0121	CbGeAlD
Amiloride—SCNN1A—lymph node—stomach cancer	0.001	0.0112	CbGeAlD
Amiloride—SLC22A2—digestive system—stomach cancer	0.000948	0.0106	CbGeAlD
Amiloride—SLC22A4—digestive system—stomach cancer	0.000703	0.00786	CbGeAlD
Amiloride—SLC22A4—bone marrow—stomach cancer	0.000648	0.00724	CbGeAlD
Amiloride—SLC22A1—endocrine gland—stomach cancer	0.000553	0.00618	CbGeAlD
Amiloride—SLC22A1—liver—stomach cancer	0.000499	0.00557	CbGeAlD
Amiloride—SLC22A4—lymph node—stomach cancer	0.000402	0.00449	CbGeAlD
Amiloride—Visual impairment—Capecitabine—stomach cancer	0.000221	0.00239	CcSEcCtD
Amiloride—Insomnia—Irinotecan—stomach cancer	0.00022	0.00238	CcSEcCtD
Amiloride—Paraesthesia—Irinotecan—stomach cancer	0.000218	0.00236	CcSEcCtD
Amiloride—Dyspnoea—Irinotecan—stomach cancer	0.000217	0.00235	CcSEcCtD
Amiloride—Somnolence—Irinotecan—stomach cancer	0.000216	0.00234	CcSEcCtD
Amiloride—Hyponatraemia—Doxorubicin—stomach cancer	0.000214	0.00232	CcSEcCtD
Amiloride—Dyspepsia—Irinotecan—stomach cancer	0.000214	0.00232	CcSEcCtD
Amiloride—Tinnitus—Capecitabine—stomach cancer	0.000213	0.00231	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.000213	0.00231	CcSEcCtD
Amiloride—Pain in extremity—Doxorubicin—stomach cancer	0.000213	0.00231	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000212	0.0023	CcSEcCtD
Amiloride—Decreased appetite—Irinotecan—stomach cancer	0.000211	0.00229	CcSEcCtD
Amiloride—Orthostatic hypotension—Epirubicin—stomach cancer	0.00021	0.00228	CcSEcCtD
Amiloride—Insomnia—Fluorouracil—stomach cancer	0.00021	0.00228	CcSEcCtD
Amiloride—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00021	0.00227	CcSEcCtD
Amiloride—Fatigue—Irinotecan—stomach cancer	0.000209	0.00227	CcSEcCtD
Amiloride—Paraesthesia—Fluorouracil—stomach cancer	0.000209	0.00226	CcSEcCtD
Amiloride—Alopecia—Docetaxel—stomach cancer	0.000209	0.00226	CcSEcCtD
Amiloride—Constipation—Irinotecan—stomach cancer	0.000208	0.00225	CcSEcCtD
Amiloride—Pain—Irinotecan—stomach cancer	0.000208	0.00225	CcSEcCtD
Amiloride—Dyspnoea—Fluorouracil—stomach cancer	0.000207	0.00225	CcSEcCtD
Amiloride—Somnolence—Fluorouracil—stomach cancer	0.000207	0.00224	CcSEcCtD
Amiloride—Dyspepsia—Fluorouracil—stomach cancer	0.000205	0.00222	CcSEcCtD
Amiloride—Muscular weakness—Epirubicin—stomach cancer	0.000203	0.0022	CcSEcCtD
Amiloride—Decreased appetite—Fluorouracil—stomach cancer	0.000202	0.00219	CcSEcCtD
Amiloride—Alopecia—Capecitabine—stomach cancer	0.000202	0.00219	CcSEcCtD
Amiloride—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000201	0.00218	CcSEcCtD
Amiloride—Abdominal distension—Epirubicin—stomach cancer	0.000201	0.00217	CcSEcCtD
Amiloride—Feeling abnormal—Irinotecan—stomach cancer	0.0002	0.00217	CcSEcCtD
Amiloride—Back pain—Docetaxel—stomach cancer	0.000199	0.00216	CcSEcCtD
Amiloride—Dysuria—Methotrexate—stomach cancer	0.000199	0.00216	CcSEcCtD
Amiloride—Neutropenia—Methotrexate—stomach cancer	0.000199	0.00216	CcSEcCtD
Amiloride—Pain—Fluorouracil—stomach cancer	0.000199	0.00216	CcSEcCtD
Amiloride—Gastrointestinal pain—Irinotecan—stomach cancer	0.000199	0.00215	CcSEcCtD
Amiloride—Muscle spasms—Docetaxel—stomach cancer	0.000198	0.00214	CcSEcCtD
Amiloride—Flatulence—Capecitabine—stomach cancer	0.000196	0.00213	CcSEcCtD
Amiloride—Erectile dysfunction—Methotrexate—stomach cancer	0.000196	0.00212	CcSEcCtD
Amiloride—Orthostatic hypotension—Doxorubicin—stomach cancer	0.000195	0.00211	CcSEcCtD
Amiloride—Angina pectoris—Epirubicin—stomach cancer	0.000194	0.0021	CcSEcCtD
Amiloride—Back pain—Capecitabine—stomach cancer	0.000193	0.00209	CcSEcCtD
Amiloride—Abdominal pain—Irinotecan—stomach cancer	0.000192	0.00208	CcSEcCtD
Amiloride—Feeling abnormal—Fluorouracil—stomach cancer	0.000192	0.00208	CcSEcCtD
Amiloride—Muscle spasms—Capecitabine—stomach cancer	0.000192	0.00208	CcSEcCtD
Amiloride—Depression—Methotrexate—stomach cancer	0.000189	0.00205	CcSEcCtD
Amiloride—Muscular weakness—Doxorubicin—stomach cancer	0.000188	0.00204	CcSEcCtD
Amiloride—Tremor—Capecitabine—stomach cancer	0.000187	0.00202	CcSEcCtD
Amiloride—Neutropenia—Epirubicin—stomach cancer	0.000186	0.00202	CcSEcCtD
Amiloride—Dysuria—Epirubicin—stomach cancer	0.000186	0.00202	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—stomach cancer	0.000186	0.00201	CcSEcCtD
Amiloride—Pollakiuria—Epirubicin—stomach cancer	0.000184	0.00199	CcSEcCtD
Amiloride—Palpitations—Docetaxel—stomach cancer	0.000182	0.00197	CcSEcCtD
Amiloride—Cough—Docetaxel—stomach cancer	0.00018	0.00195	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—stomach cancer	0.00018	0.00195	CcSEcCtD
Amiloride—Vertigo—Capecitabine—stomach cancer	0.000179	0.00194	CcSEcCtD
Amiloride—Palpitations—Capecitabine—stomach cancer	0.000176	0.00191	CcSEcCtD
Amiloride—Arthralgia—Docetaxel—stomach cancer	0.000175	0.0019	CcSEcCtD
Amiloride—Chest pain—Docetaxel—stomach cancer	0.000175	0.0019	CcSEcCtD
Amiloride—Asthenia—Irinotecan—stomach cancer	0.000174	0.00189	CcSEcCtD
Amiloride—Cough—Capecitabine—stomach cancer	0.000174	0.00188	CcSEcCtD
Amiloride—Jaundice—Epirubicin—stomach cancer	0.000173	0.00188	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—stomach cancer	0.000172	0.00187	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—stomach cancer	0.000172	0.00187	CcSEcCtD
Amiloride—Haemoglobin—Methotrexate—stomach cancer	0.000171	0.00186	CcSEcCtD
Amiloride—Haemorrhage—Methotrexate—stomach cancer	0.00017	0.00185	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—stomach cancer	0.00017	0.00184	CcSEcCtD
Amiloride—Arthralgia—Capecitabine—stomach cancer	0.00017	0.00184	CcSEcCtD
Amiloride—Chest pain—Capecitabine—stomach cancer	0.00017	0.00184	CcSEcCtD
Amiloride—Confusional state—Docetaxel—stomach cancer	0.000169	0.00183	CcSEcCtD
Amiloride—Diarrhoea—Irinotecan—stomach cancer	0.000166	0.0018	CcSEcCtD
Amiloride—Shock—Docetaxel—stomach cancer	0.000165	0.00179	CcSEcCtD
Amiloride—Pruritus—Fluorouracil—stomach cancer	0.000165	0.00178	CcSEcCtD
Amiloride—Visual impairment—Methotrexate—stomach cancer	0.000164	0.00178	CcSEcCtD
Amiloride—Confusional state—Capecitabine—stomach cancer	0.000164	0.00178	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—stomach cancer	0.000162	0.00176	CcSEcCtD
Amiloride—Dizziness—Irinotecan—stomach cancer	0.000161	0.00174	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—stomach cancer	0.00016	0.00174	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—stomach cancer	0.00016	0.00174	CcSEcCtD
Amiloride—Anorexia—Docetaxel—stomach cancer	0.00016	0.00173	CcSEcCtD
Amiloride—Shock—Capecitabine—stomach cancer	0.00016	0.00173	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—stomach cancer	0.000159	0.00173	CcSEcCtD
Amiloride—Diarrhoea—Fluorouracil—stomach cancer	0.000159	0.00172	CcSEcCtD
Amiloride—Tinnitus—Methotrexate—stomach cancer	0.000159	0.00172	CcSEcCtD
Amiloride—Anorexia—Capecitabine—stomach cancer	0.000155	0.00168	CcSEcCtD
Amiloride—Vomiting—Irinotecan—stomach cancer	0.000154	0.00167	CcSEcCtD
Amiloride—Dizziness—Fluorouracil—stomach cancer	0.000154	0.00167	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—stomach cancer	0.000154	0.00166	CcSEcCtD
Amiloride—Rash—Irinotecan—stomach cancer	0.000153	0.00166	CcSEcCtD
Amiloride—Dermatitis—Irinotecan—stomach cancer	0.000153	0.00166	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000153	0.00166	CcSEcCtD
Amiloride—Headache—Irinotecan—stomach cancer	0.000152	0.00165	CcSEcCtD
Amiloride—Insomnia—Docetaxel—stomach cancer	0.000152	0.00165	CcSEcCtD
Amiloride—Paraesthesia—Docetaxel—stomach cancer	0.000151	0.00163	CcSEcCtD
Amiloride—Alopecia—Methotrexate—stomach cancer	0.000151	0.00163	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—stomach cancer	0.00015	0.00163	CcSEcCtD
Amiloride—Dyspnoea—Docetaxel—stomach cancer	0.00015	0.00162	CcSEcCtD
Amiloride—Somnolence—Docetaxel—stomach cancer	0.000149	0.00162	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—stomach cancer	0.000149	0.00161	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—stomach cancer	0.000148	0.00161	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000148	0.00161	CcSEcCtD
Amiloride—Vomiting—Fluorouracil—stomach cancer	0.000148	0.0016	CcSEcCtD
Amiloride—Dyspepsia—Docetaxel—stomach cancer	0.000148	0.0016	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—stomach cancer	0.000148	0.0016	CcSEcCtD
Amiloride—Insomnia—Capecitabine—stomach cancer	0.000147	0.00159	CcSEcCtD
Amiloride—Rash—Fluorouracil—stomach cancer	0.000147	0.00159	CcSEcCtD
Amiloride—Dermatitis—Fluorouracil—stomach cancer	0.000147	0.00159	CcSEcCtD
Amiloride—Paraesthesia—Capecitabine—stomach cancer	0.000146	0.00158	CcSEcCtD
Amiloride—Decreased appetite—Docetaxel—stomach cancer	0.000146	0.00158	CcSEcCtD
Amiloride—Headache—Fluorouracil—stomach cancer	0.000146	0.00158	CcSEcCtD
Amiloride—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000145	0.00157	CcSEcCtD
Amiloride—Dyspnoea—Capecitabine—stomach cancer	0.000145	0.00157	CcSEcCtD
Amiloride—Fatigue—Docetaxel—stomach cancer	0.000145	0.00157	CcSEcCtD
Amiloride—Nausea—Irinotecan—stomach cancer	0.000144	0.00156	CcSEcCtD
Amiloride—Pain—Docetaxel—stomach cancer	0.000144	0.00156	CcSEcCtD
Amiloride—Constipation—Docetaxel—stomach cancer	0.000144	0.00156	CcSEcCtD
Amiloride—Back pain—Methotrexate—stomach cancer	0.000143	0.00155	CcSEcCtD
Amiloride—Dyspepsia—Capecitabine—stomach cancer	0.000143	0.00155	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—stomach cancer	0.000142	0.00154	CcSEcCtD
Amiloride—Decreased appetite—Capecitabine—stomach cancer	0.000141	0.00153	CcSEcCtD
Amiloride—Alopecia—Epirubicin—stomach cancer	0.000141	0.00153	CcSEcCtD
Amiloride—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00014	0.00152	CcSEcCtD
Amiloride—Fatigue—Capecitabine—stomach cancer	0.00014	0.00152	CcSEcCtD
Amiloride—Constipation—Capecitabine—stomach cancer	0.000139	0.00151	CcSEcCtD
Amiloride—Pain—Capecitabine—stomach cancer	0.000139	0.00151	CcSEcCtD
Amiloride—Feeling abnormal—Docetaxel—stomach cancer	0.000138	0.0015	CcSEcCtD
Amiloride—Nausea—Fluorouracil—stomach cancer	0.000138	0.0015	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—stomach cancer	0.000138	0.00149	CcSEcCtD
Amiloride—Gastrointestinal pain—Docetaxel—stomach cancer	0.000137	0.00149	CcSEcCtD
Amiloride—Flatulence—Epirubicin—stomach cancer	0.000137	0.00148	CcSEcCtD
Amiloride—Tension—Epirubicin—stomach cancer	0.000136	0.00148	CcSEcCtD
Amiloride—Nervousness—Epirubicin—stomach cancer	0.000135	0.00146	CcSEcCtD
Amiloride—Back pain—Epirubicin—stomach cancer	0.000134	0.00145	CcSEcCtD
Amiloride—Feeling abnormal—Capecitabine—stomach cancer	0.000134	0.00145	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—stomach cancer	0.000133	0.00145	CcSEcCtD
Amiloride—Vertigo—Methotrexate—stomach cancer	0.000133	0.00144	CcSEcCtD
Amiloride—Gastrointestinal pain—Capecitabine—stomach cancer	0.000133	0.00144	CcSEcCtD
Amiloride—Abdominal pain—Docetaxel—stomach cancer	0.000133	0.00144	CcSEcCtD
Amiloride—Alopecia—Doxorubicin—stomach cancer	0.00013	0.00141	CcSEcCtD
Amiloride—Cough—Methotrexate—stomach cancer	0.000129	0.0014	CcSEcCtD
Amiloride—Abdominal pain—Capecitabine—stomach cancer	0.000129	0.00139	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—stomach cancer	0.000127	0.00137	CcSEcCtD
Amiloride—Arthralgia—Methotrexate—stomach cancer	0.000126	0.00137	CcSEcCtD
Amiloride—Chest pain—Methotrexate—stomach cancer	0.000126	0.00137	CcSEcCtD
Amiloride—Tension—Doxorubicin—stomach cancer	0.000126	0.00137	CcSEcCtD
Amiloride—Nervousness—Doxorubicin—stomach cancer	0.000125	0.00135	CcSEcCtD
Amiloride—Vertigo—Epirubicin—stomach cancer	0.000125	0.00135	CcSEcCtD
Amiloride—Back pain—Doxorubicin—stomach cancer	0.000124	0.00135	CcSEcCtD
Amiloride—Muscle spasms—Doxorubicin—stomach cancer	0.000123	0.00134	CcSEcCtD
Amiloride—Palpitations—Epirubicin—stomach cancer	0.000123	0.00133	CcSEcCtD
Amiloride—Confusional state—Methotrexate—stomach cancer	0.000122	0.00132	CcSEcCtD
Amiloride—Cough—Epirubicin—stomach cancer	0.000121	0.00131	CcSEcCtD
Amiloride—Asthenia—Docetaxel—stomach cancer	0.00012	0.00131	CcSEcCtD
Amiloride—Pruritus—Docetaxel—stomach cancer	0.000119	0.00129	CcSEcCtD
Amiloride—Chest pain—Epirubicin—stomach cancer	0.000118	0.00128	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—stomach cancer	0.000118	0.00128	CcSEcCtD
Amiloride—Asthenia—Capecitabine—stomach cancer	0.000117	0.00126	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—stomach cancer	0.000115	0.00125	CcSEcCtD
Amiloride—Anorexia—Methotrexate—stomach cancer	0.000115	0.00125	CcSEcCtD
Amiloride—Pruritus—Capecitabine—stomach cancer	0.000115	0.00125	CcSEcCtD
Amiloride—Diarrhoea—Docetaxel—stomach cancer	0.000115	0.00124	CcSEcCtD
Amiloride—Confusional state—Epirubicin—stomach cancer	0.000114	0.00124	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—stomach cancer	0.000113	0.00123	CcSEcCtD
Amiloride—Cough—Doxorubicin—stomach cancer	0.000112	0.00121	CcSEcCtD
Amiloride—Shock—Epirubicin—stomach cancer	0.000111	0.00121	CcSEcCtD
Amiloride—Diarrhoea—Capecitabine—stomach cancer	0.000111	0.00121	CcSEcCtD
Amiloride—Dizziness—Docetaxel—stomach cancer	0.000111	0.0012	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.00011	0.00119	CcSEcCtD
Amiloride—Insomnia—Methotrexate—stomach cancer	0.000109	0.00119	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—stomach cancer	0.000109	0.00118	CcSEcCtD
Amiloride—Arthralgia—Doxorubicin—stomach cancer	0.000109	0.00118	CcSEcCtD
Amiloride—Paraesthesia—Methotrexate—stomach cancer	0.000109	0.00118	CcSEcCtD
Amiloride—Anorexia—Epirubicin—stomach cancer	0.000108	0.00117	CcSEcCtD
Amiloride—Dyspnoea—Methotrexate—stomach cancer	0.000108	0.00117	CcSEcCtD
Amiloride—Somnolence—Methotrexate—stomach cancer	0.000108	0.00117	CcSEcCtD
Amiloride—Dizziness—Capecitabine—stomach cancer	0.000108	0.00116	CcSEcCtD
Amiloride—Vomiting—Docetaxel—stomach cancer	0.000107	0.00116	CcSEcCtD
Amiloride—Dyspepsia—Methotrexate—stomach cancer	0.000107	0.00115	CcSEcCtD
Amiloride—Rash—Docetaxel—stomach cancer	0.000106	0.00115	CcSEcCtD
Amiloride—Dermatitis—Docetaxel—stomach cancer	0.000106	0.00115	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—stomach cancer	0.000106	0.00115	CcSEcCtD
Amiloride—Decreased appetite—Methotrexate—stomach cancer	0.000105	0.00114	CcSEcCtD
Amiloride—Headache—Docetaxel—stomach cancer	0.000105	0.00114	CcSEcCtD
Amiloride—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000104	0.00113	CcSEcCtD
Amiloride—Fatigue—Methotrexate—stomach cancer	0.000104	0.00113	CcSEcCtD
Amiloride—Pain—Methotrexate—stomach cancer	0.000103	0.00112	CcSEcCtD
Amiloride—Vomiting—Capecitabine—stomach cancer	0.000103	0.00112	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000103	0.00112	CcSEcCtD
Amiloride—Shock—Doxorubicin—stomach cancer	0.000103	0.00112	CcSEcCtD
Amiloride—Rash—Capecitabine—stomach cancer	0.000103	0.00111	CcSEcCtD
Amiloride—Insomnia—Epirubicin—stomach cancer	0.000102	0.00111	CcSEcCtD
Amiloride—Dermatitis—Capecitabine—stomach cancer	0.000102	0.00111	CcSEcCtD
Amiloride—Headache—Capecitabine—stomach cancer	0.000102	0.0011	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—stomach cancer	0.000102	0.0011	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—stomach cancer	0.000101	0.00109	CcSEcCtD
Amiloride—Somnolence—Epirubicin—stomach cancer	0.000101	0.00109	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—stomach cancer	9.99e-05	0.00108	CcSEcCtD
Amiloride—Nausea—Docetaxel—stomach cancer	9.97e-05	0.00108	CcSEcCtD
Amiloride—Feeling abnormal—Methotrexate—stomach cancer	9.97e-05	0.00108	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—stomach cancer	9.97e-05	0.00108	CcSEcCtD
Amiloride—Gastrointestinal pain—Methotrexate—stomach cancer	9.9e-05	0.00107	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—stomach cancer	9.85e-05	0.00107	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—stomach cancer	9.78e-05	0.00106	CcSEcCtD
Amiloride—Fatigue—Epirubicin—stomach cancer	9.77e-05	0.00106	CcSEcCtD
Amiloride—Constipation—Epirubicin—stomach cancer	9.69e-05	0.00105	CcSEcCtD
Amiloride—Pain—Epirubicin—stomach cancer	9.69e-05	0.00105	CcSEcCtD
Amiloride—Nausea—Capecitabine—stomach cancer	9.66e-05	0.00105	CcSEcCtD
Amiloride—SLC9A1—ErbB1 downstream signaling—HRAS—stomach cancer	9.62e-05	0.000696	CbGpPWpGaD
Amiloride—Abdominal pain—Methotrexate—stomach cancer	9.57e-05	0.00104	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.55e-05	0.00103	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK3—stomach cancer	9.52e-05	0.000689	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ALB—stomach cancer	9.51e-05	0.000688	CbGpPWpGaD
Amiloride—Insomnia—Doxorubicin—stomach cancer	9.48e-05	0.00103	CcSEcCtD
Amiloride—Paraesthesia—Doxorubicin—stomach cancer	9.41e-05	0.00102	CcSEcCtD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—ALB—stomach cancer	9.35e-05	0.000677	CbGpPWpGaD
Amiloride—Dyspnoea—Doxorubicin—stomach cancer	9.34e-05	0.00101	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—stomach cancer	9.33e-05	0.00101	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—stomach cancer	9.32e-05	0.00101	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—stomach cancer	9.28e-05	0.000672	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Epirubicin—stomach cancer	9.26e-05	0.001	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALDH7A1—stomach cancer	9.23e-05	0.000668	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PLCE1—stomach cancer	9.23e-05	0.000668	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—SLC1A2—stomach cancer	9.23e-05	0.000668	CbGpPWpGaD
Amiloride—Dyspepsia—Doxorubicin—stomach cancer	9.23e-05	0.001	CcSEcCtD
Amiloride—Decreased appetite—Doxorubicin—stomach cancer	9.11e-05	0.000987	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—PIK3CA—stomach cancer	9.1e-05	0.000659	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—APOA1—stomach cancer	9.1e-05	0.000658	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—APOA1—stomach cancer	9.1e-05	0.000658	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—APOA1—stomach cancer	9.1e-05	0.000658	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—APOA1—stomach cancer	9.1e-05	0.000658	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—APOA1—stomach cancer	9.1e-05	0.000658	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—stomach cancer	9.07e-05	0.000656	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—MAPK1—stomach cancer	9.06e-05	0.000655	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—EGFR—stomach cancer	9.05e-05	0.000655	CbGpPWpGaD
Amiloride—Gastrointestinal disorder—Doxorubicin—stomach cancer	9.05e-05	0.00098	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—stomach cancer	9.04e-05	0.000979	CcSEcCtD
Amiloride—Constipation—Doxorubicin—stomach cancer	8.96e-05	0.000971	CcSEcCtD
Amiloride—Pain—Doxorubicin—stomach cancer	8.96e-05	0.000971	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—stomach cancer	8.95e-05	0.00097	CcSEcCtD
Amiloride—SLC9A1—Metabolism—UMPS—stomach cancer	8.85e-05	0.00064	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—stomach cancer	8.8e-05	0.000637	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—CLCN3—stomach cancer	8.73e-05	0.000632	CbGpPWpGaD
Amiloride—Asthenia—Methotrexate—stomach cancer	8.68e-05	0.000941	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—HRAS—stomach cancer	8.68e-05	0.000628	CbGpPWpGaD
Amiloride—Feeling abnormal—Doxorubicin—stomach cancer	8.64e-05	0.000936	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—SLC1A2—stomach cancer	8.6e-05	0.000622	CbGpPWpGaD
Amiloride—Gastrointestinal pain—Doxorubicin—stomach cancer	8.57e-05	0.000929	CcSEcCtD
Amiloride—Pruritus—Methotrexate—stomach cancer	8.56e-05	0.000928	CcSEcCtD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—KRAS—stomach cancer	8.55e-05	0.000619	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PPP2R1A—stomach cancer	8.52e-05	0.000617	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—HRAS—stomach cancer	8.42e-05	0.000609	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IL6—stomach cancer	8.3e-05	0.000601	CbGpPWpGaD
Amiloride—Abdominal pain—Doxorubicin—stomach cancer	8.28e-05	0.000898	CcSEcCtD
Amiloride—Diarrhoea—Methotrexate—stomach cancer	8.28e-05	0.000897	CcSEcCtD
Amiloride—SLC9A1—Metabolism—PDHA1—stomach cancer	8.22e-05	0.000595	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ECHS1—stomach cancer	8.22e-05	0.000595	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	8.14e-05	0.000589	CbGpPWpGaD
Amiloride—Asthenia—Epirubicin—stomach cancer	8.13e-05	0.000881	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC1A2—stomach cancer	8.04e-05	0.000581	CbGpPWpGaD
Amiloride—Pruritus—Epirubicin—stomach cancer	8.01e-05	0.000868	CcSEcCtD
Amiloride—SLC9A1—Disease—ALDOB—stomach cancer	8.01e-05	0.000579	CbGpPWpGaD
Amiloride—Dizziness—Methotrexate—stomach cancer	8e-05	0.000867	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	7.91e-05	0.000573	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—PIK3CA—stomach cancer	7.86e-05	0.000569	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPL15—stomach cancer	7.85e-05	0.000568	CbGpPWpGaD
Amiloride—Diarrhoea—Epirubicin—stomach cancer	7.75e-05	0.00084	CcSEcCtD
Amiloride—SLC9A1—Metabolism—FADS1—stomach cancer	7.73e-05	0.00056	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TYMP—stomach cancer	7.73e-05	0.00056	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NPM1—stomach cancer	7.71e-05	0.000558	CbGpPWpGaD
Amiloride—Vomiting—Methotrexate—stomach cancer	7.7e-05	0.000834	CcSEcCtD
Amiloride—Rash—Methotrexate—stomach cancer	7.63e-05	0.000827	CcSEcCtD
Amiloride—Dermatitis—Methotrexate—stomach cancer	7.62e-05	0.000826	CcSEcCtD
Amiloride—Headache—Methotrexate—stomach cancer	7.58e-05	0.000822	CcSEcCtD
Amiloride—Asthenia—Doxorubicin—stomach cancer	7.52e-05	0.000815	CcSEcCtD
Amiloride—PLAU—Hemostasis—FYN—stomach cancer	7.52e-05	0.000544	CbGpPWpGaD
Amiloride—Dizziness—Epirubicin—stomach cancer	7.49e-05	0.000812	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	7.48e-05	0.000541	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RBP4—stomach cancer	7.44e-05	0.000539	CbGpPWpGaD
Amiloride—Pruritus—Doxorubicin—stomach cancer	7.41e-05	0.000803	CcSEcCtD
Amiloride—SLC9A1—Disease—RPS26—stomach cancer	7.32e-05	0.00053	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PPIA—stomach cancer	7.26e-05	0.000526	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—SREBF2—stomach cancer	7.24e-05	0.000524	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ALB—stomach cancer	7.21e-05	0.000522	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ALB—stomach cancer	7.21e-05	0.000522	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ALB—stomach cancer	7.21e-05	0.000522	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ALB—stomach cancer	7.21e-05	0.000522	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ALB—stomach cancer	7.21e-05	0.000522	CbGpPWpGaD
Amiloride—Vomiting—Epirubicin—stomach cancer	7.2e-05	0.00078	CcSEcCtD
Amiloride—Nausea—Methotrexate—stomach cancer	7.19e-05	0.000779	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—stomach cancer	7.17e-05	0.000777	CcSEcCtD
Amiloride—SLC9A1—Metabolism—RORA—stomach cancer	7.15e-05	0.000518	CbGpPWpGaD
Amiloride—Rash—Epirubicin—stomach cancer	7.14e-05	0.000774	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—stomach cancer	7.13e-05	0.000773	CcSEcCtD
Amiloride—Headache—Epirubicin—stomach cancer	7.1e-05	0.000769	CcSEcCtD
Amiloride—SLC22A2—Neuronal System—SLC1A2—stomach cancer	7.07e-05	0.000511	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	6.97e-05	0.000504	CbGpPWpGaD
Amiloride—Dizziness—Doxorubicin—stomach cancer	6.93e-05	0.000751	CcSEcCtD
Amiloride—Nausea—Epirubicin—stomach cancer	6.73e-05	0.000729	CcSEcCtD
Amiloride—SLC9A1—Metabolism—ALDOB—stomach cancer	6.7e-05	0.000485	CbGpPWpGaD
Amiloride—Vomiting—Doxorubicin—stomach cancer	6.66e-05	0.000722	CcSEcCtD
Amiloride—Rash—Doxorubicin—stomach cancer	6.61e-05	0.000716	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—stomach cancer	6.6e-05	0.000715	CcSEcCtD
Amiloride—SLC22A1—Neuronal System—SLC1A2—stomach cancer	6.59e-05	0.000477	CbGpPWpGaD
Amiloride—Headache—Doxorubicin—stomach cancer	6.57e-05	0.000711	CcSEcCtD
Amiloride—PLAU—Hemostasis—CAV1—stomach cancer	6.26e-05	0.000453	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—APOA1—stomach cancer	6.25e-05	0.000452	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALOX5—stomach cancer	6.23e-05	0.000451	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPS19—stomach cancer	6.23e-05	0.00045	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKR1C3—stomach cancer	6.23e-05	0.00045	CbGpPWpGaD
Amiloride—Nausea—Doxorubicin—stomach cancer	6.23e-05	0.000675	CcSEcCtD
Amiloride—SLC9A1—Metabolism—DPYD—stomach cancer	6.13e-05	0.000444	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ENO1—stomach cancer	6.07e-05	0.000439	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—APOA1—stomach cancer	6e-05	0.000434	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PRKCB—stomach cancer	5.96e-05	0.000431	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HSPA8—stomach cancer	5.51e-05	0.000399	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RPS6—stomach cancer	5.51e-05	0.000398	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTT1—stomach cancer	5.42e-05	0.000392	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CD44—stomach cancer	5.38e-05	0.000389	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CYP2A6—stomach cancer	5.36e-05	0.000388	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKR1C3—stomach cancer	5.21e-05	0.000377	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HSPA8—stomach cancer	5.14e-05	0.000372	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ENO1—stomach cancer	5.08e-05	0.000368	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HBEGF—stomach cancer	5.06e-05	0.000366	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—SERPINE1—stomach cancer	4.96e-05	0.000359	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—ALB—stomach cancer	4.95e-05	0.000358	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—RHOA—stomach cancer	4.79e-05	0.000346	CbGpPWpGaD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ALB—stomach cancer	4.75e-05	0.000344	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—NOS3—stomach cancer	4.74e-05	0.000343	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PPP2R1A—stomach cancer	4.58e-05	0.000331	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CD44—stomach cancer	4.51e-05	0.000326	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—ALB—stomach cancer	4.28e-05	0.00031	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SMAD4—stomach cancer	4.25e-05	0.000307	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HSPA8—stomach cancer	4.22e-05	0.000306	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ACAD8—stomach cancer	4.09e-05	0.000296	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FYN—stomach cancer	4.03e-05	0.000292	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HSPA8—stomach cancer	3.94e-05	0.000285	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERCC2—stomach cancer	3.88e-05	0.000281	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPP2R1A—stomach cancer	3.83e-05	0.000277	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ACAD8—stomach cancer	3.81e-05	0.000276	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	3.8e-05	0.000275	CbGpPWpGaD
Amiloride—SLC9A1—Disease—FGFR2—stomach cancer	3.79e-05	0.000274	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTP1—stomach cancer	3.76e-05	0.000272	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HMOX1—stomach cancer	3.71e-05	0.000268	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GMPR2—stomach cancer	3.65e-05	0.000264	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MTHFR—stomach cancer	3.64e-05	0.000264	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—HMOX1—stomach cancer	3.62e-05	0.000262	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	3.54e-05	0.000256	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TYMS—stomach cancer	3.49e-05	0.000253	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IRS2—stomach cancer	3.47e-05	0.000251	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GSTM1—stomach cancer	3.45e-05	0.00025	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—VEGFA—stomach cancer	3.41e-05	0.000247	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GMPR2—stomach cancer	3.4e-05	0.000246	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CAV1—stomach cancer	3.36e-05	0.000243	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APOA1—stomach cancer	3.35e-05	0.000243	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SUCLG1—stomach cancer	3.33e-05	0.000241	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—IDH3B—stomach cancer	3.33e-05	0.000241	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ERCC2—stomach cancer	3.25e-05	0.000235	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK3—stomach cancer	3.23e-05	0.000234	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6ST—stomach cancer	3.19e-05	0.000231	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—IDH3B—stomach cancer	3.11e-05	0.000225	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SUCLG1—stomach cancer	3.11e-05	0.000225	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NDUFS1—stomach cancer	3.1e-05	0.000224	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NDUFV1—stomach cancer	3.1e-05	0.000224	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—MAPK1—stomach cancer	3.07e-05	0.000222	CbGpPWpGaD
Amiloride—SLC9A1—Disease—APC—stomach cancer	3.06e-05	0.000222	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—MTHFR—stomach cancer	3.05e-05	0.000221	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—PRKCB—stomach cancer	3.01e-05	0.000218	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—KRAS—stomach cancer	2.9e-05	0.00021	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NDUFV1—stomach cancer	2.89e-05	0.000209	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NDUFS1—stomach cancer	2.89e-05	0.000209	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6R—stomach cancer	2.84e-05	0.000206	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—CAV1—stomach cancer	2.82e-05	0.000204	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—APOA1—stomach cancer	2.81e-05	0.000203	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—PRKCB—stomach cancer	2.8e-05	0.000203	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BLVRB—stomach cancer	2.76e-05	0.0002	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PGLS—stomach cancer	2.76e-05	0.0002	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—APOA1—stomach cancer	2.74e-05	0.000199	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—PIK3CA—stomach cancer	2.67e-05	0.000193	CbGpPWpGaD
Amiloride—SLC9A1—Disease—SERPINE1—stomach cancer	2.66e-05	0.000193	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPAP2A—stomach cancer	2.64e-05	0.000191	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—TP53—stomach cancer	2.58e-05	0.000187	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BLVRB—stomach cancer	2.57e-05	0.000186	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PGLS—stomach cancer	2.57e-05	0.000186	CbGpPWpGaD
Amiloride—SLC9A1—Disease—RHOA—stomach cancer	2.57e-05	0.000186	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NOS3—stomach cancer	2.54e-05	0.000184	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPARG—stomach cancer	2.48e-05	0.000179	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—stomach cancer	2.47e-05	0.000178	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPAP2A—stomach cancer	2.46e-05	0.000178	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—stomach cancer	2.38e-05	0.000172	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FBP1—stomach cancer	2.35e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NDUFA2—stomach cancer	2.35e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA1—stomach cancer	2.35e-05	0.00017	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CKB—stomach cancer	2.35e-05	0.00017	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PTGS2—stomach cancer	2.33e-05	0.000168	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—PRKCB—stomach cancer	2.3e-05	0.000167	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ALB—stomach cancer	2.23e-05	0.000161	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLIN2—stomach cancer	2.21e-05	0.00016	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1B—stomach cancer	2.2e-05	0.000159	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FBP1—stomach cancer	2.19e-05	0.000158	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA1—stomach cancer	2.19e-05	0.000158	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NDUFA2—stomach cancer	2.19e-05	0.000158	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CKB—stomach cancer	2.19e-05	0.000158	CbGpPWpGaD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ALB—stomach cancer	2.17e-05	0.000157	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CA2—stomach cancer	2.15e-05	0.000155	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—PRKCB—stomach cancer	2.15e-05	0.000155	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—NOS3—stomach cancer	2.13e-05	0.000154	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PGAM1—stomach cancer	2.09e-05	0.000151	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NT5E—stomach cancer	2.09e-05	0.000151	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLIN2—stomach cancer	2.06e-05	0.000149	CbGpPWpGaD
Amiloride—SLC9A1—Disease—CDKN1A—stomach cancer	2.03e-05	0.000147	CbGpPWpGaD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—ALB—stomach cancer	2.02e-05	0.000146	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CA2—stomach cancer	2e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PLCE1—stomach cancer	2e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDH7A1—stomach cancer	2e-05	0.000145	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NT5E—stomach cancer	1.95e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PGAM1—stomach cancer	1.95e-05	0.000141	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PTGS2—stomach cancer	1.95e-05	0.000141	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—UMPS—stomach cancer	1.91e-05	0.000139	CbGpPWpGaD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—ALB—stomach cancer	1.89e-05	0.000137	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDH7A1—stomach cancer	1.86e-05	0.000135	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PLCE1—stomach cancer	1.86e-05	0.000135	CbGpPWpGaD
Amiloride—SLC9A1—Disease—STAT3—stomach cancer	1.81e-05	0.000131	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—UMPS—stomach cancer	1.78e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PDHA1—stomach cancer	1.78e-05	0.000129	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ECHS1—stomach cancer	1.78e-05	0.000129	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK3—stomach cancer	1.73e-05	0.000125	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.71e-05	0.000124	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—stomach cancer	1.69e-05	0.000122	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TYMP—stomach cancer	1.67e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—FADS1—stomach cancer	1.67e-05	0.000121	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ECHS1—stomach cancer	1.66e-05	0.00012	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PDHA1—stomach cancer	1.66e-05	0.00012	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MAPK1—stomach cancer	1.65e-05	0.000119	CbGpPWpGaD
Amiloride—SLC9A1—Disease—EGFR—stomach cancer	1.65e-05	0.000119	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	1.6e-05	0.000116	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SREBF2—stomach cancer	1.57e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—FADS1—stomach cancer	1.56e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TYMP—stomach cancer	1.56e-05	0.000113	CbGpPWpGaD
Amiloride—SLC9A1—Disease—KRAS—stomach cancer	1.56e-05	0.000113	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.55e-05	0.000112	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—RORA—stomach cancer	1.55e-05	0.000112	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SREBF2—stomach cancer	1.46e-05	0.000106	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALDOB—stomach cancer	1.45e-05	0.000105	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—MAPK1—stomach cancer	1.44e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—RORA—stomach cancer	1.44e-05	0.000104	CbGpPWpGaD
Amiloride—SLC9A1—Disease—PIK3CA—stomach cancer	1.43e-05	0.000104	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALDOB—stomach cancer	1.35e-05	9.79e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALOX5—stomach cancer	1.35e-05	9.76e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—DPYD—stomach cancer	1.33e-05	9.6e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—stomach cancer	1.32e-05	9.58e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—APOA1—stomach cancer	1.3e-05	9.39e-05	CbGpPWpGaD
Amiloride—SLC9A1—Disease—IL6—stomach cancer	1.27e-05	9.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALOX5—stomach cancer	1.26e-05	9.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—stomach cancer	1.24e-05	9e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—DPYD—stomach cancer	1.24e-05	8.95e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.21e-05	8.76e-05	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PIK3CA—stomach cancer	1.2e-05	8.67e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—MAPK1—stomach cancer	1.19e-05	8.59e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTT1—stomach cancer	1.17e-05	8.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CYP2A6—stomach cancer	1.16e-05	8.39e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—stomach cancer	1.16e-05	8.39e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKR1C3—stomach cancer	1.13e-05	8.17e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—MAPK1—stomach cancer	1.11e-05	8e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO1—stomach cancer	1.1e-05	7.96e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTT1—stomach cancer	1.09e-05	7.92e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CYP2A6—stomach cancer	1.08e-05	7.82e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKR1C3—stomach cancer	1.05e-05	7.61e-05	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ALB—stomach cancer	1.03e-05	7.44e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO1—stomach cancer	1.03e-05	7.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CD44—stomach cancer	9.75e-06	7.06e-05	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ALB—stomach cancer	9.59e-06	6.94e-05	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—stomach cancer	9.53e-06	6.89e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CD44—stomach cancer	9.09e-06	6.58e-05	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—stomach cancer	8.88e-06	6.42e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPP2R1A—stomach cancer	8.29e-06	6e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTP1—stomach cancer	8.13e-06	5.89e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—HMOX1—stomach cancer	8.02e-06	5.81e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPP2R1A—stomach cancer	7.73e-06	5.59e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTP1—stomach cancer	7.58e-06	5.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TYMS—stomach cancer	7.56e-06	5.47e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HMOX1—stomach cancer	7.48e-06	5.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GSTM1—stomach cancer	7.48e-06	5.41e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TYMS—stomach cancer	7.05e-06	5.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ERCC2—stomach cancer	7.03e-06	5.09e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GSTM1—stomach cancer	6.97e-06	5.04e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—MTHFR—stomach cancer	6.61e-06	4.78e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ERCC2—stomach cancer	6.55e-06	4.74e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—MTHFR—stomach cancer	6.16e-06	4.46e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—CAV1—stomach cancer	6.09e-06	4.41e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—APOA1—stomach cancer	6.08e-06	4.4e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—CAV1—stomach cancer	5.68e-06	4.11e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—APOA1—stomach cancer	5.67e-06	4.1e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PPARG—stomach cancer	5.36e-06	3.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPARG—stomach cancer	4.99e-06	3.61e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ALB—stomach cancer	4.82e-06	3.49e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NOS3—stomach cancer	4.61e-06	3.33e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ALB—stomach cancer	4.49e-06	3.25e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NOS3—stomach cancer	4.29e-06	3.11e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PTGS2—stomach cancer	4.21e-06	3.05e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PTGS2—stomach cancer	3.93e-06	2.84e-05	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—PIK3CA—stomach cancer	2.59e-06	1.88e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PIK3CA—stomach cancer	2.42e-06	1.75e-05	CbGpPWpGaD
